Wilson Troutman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Wilson Troutman
Earlier roles on record: CFO at Eton Pharmaceuticals, Inc. (ETON) until April 11, 2022. The proxy statement of Eton Pharmaceuticals, Inc. reports total compensation of $906,112 for Wilson Troutman in fiscal 2020, including a base salary of $277,083. Disclosed compensation is on record for 3 fiscal years. Wilson Troutman has spoken on 7 earnings calls across 1 company, most recently for Eton Pharmaceuticals, Inc. on March 16, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-04-11
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Eton Pharmaceuticals, Inc. (ETON) | Chief Financial Officer | $277,083 | $906,112 |
| 2019 | Eton Pharmaceuticals, Inc. (ETON) | Chief Financial Officer | $242,667 | $864,627 |
| 2018 | Eton Pharmaceuticals, Inc. (ETON) | Chief Financial Officer | $204,500 | $296,552 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.